The weekly litigation news digest is live. Subscribe now

IP Verse

Redirected, Genetically-Engineered T Regulatory Cells And Their Use In Suppression Of Autoimmune And Inflammatory Disease - EP3097923

The patent EP3097923 was granted to Yeda Research on Jul 27, 2022. The application was filed on Jan 31, 2008 under application number EP16177278A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3097923

YEDA RESEARCH
Application Number
EP16177278A
Filing Date
Jan 31, 2008
Status
Granted And Under Opposition
Jun 24, 2022
Publication Date
Jul 27, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
JG OPPOSITIONSApr 27, 2023GREGSONADMISSIBLE

Patent Citations (17) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2002137697
DESCRIPTIONUS5906936
DESCRIPTIONUS5912172
DESCRIPTIONWO0031239
DESCRIPTIONWO9319163
DESCRIPTIONWO9514710
DESCRIPTIONWO9715669
EXAMINATIONUS2003147865
OPPOSITIONEP1795599
OPPOSITIONUS2002137697
OPPOSITIONUS2003015057
OPPOSITIONUS2003147865
OPPOSITIONWO02072796
OPPOSITIONWO03066072
OPPOSITIONWO2007065957
OPPOSITIONWO9319163
OTHEREP2126054

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents